Personalized Genetic Diagnosis of Congenital Heart Defects in Newborns

被引:7
|
作者
Diz, Olga Maria [1 ,2 ]
Toro, Rocio [3 ]
Cesar, Sergi [4 ]
Gomez, Olga [5 ,6 ,7 ]
Sarquella-Brugada, Georgia [4 ,8 ]
Campuzano, Oscar [2 ,8 ,9 ]
机构
[1] Hosp Univ Puerta Mar, UGC Labs, Cadiz 11009, Spain
[2] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin Barcelona, Biochem & Mol Genet Dept, Barcelona 08950, Spain
[3] Cadiz Univ, Sch Med, Med Dept, Cadiz 11519, Spain
[4] Univ Barcelona, Hosp St Joan Deu, Inst Recerca St Joan Deu, Arrhythmia Inherited Cardiac Dis & Sudden Death U, Barcelona 08007, Spain
[5] Univ Barcelona, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Fetal Med Res Ctr, Hosp Clin, Barcelona 08950, Spain
[6] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp St Joan Deu, Barcelona 08950, Spain
[7] Ctr Biomed Res Rare Dis CIBER ER, Madrid 28029, Spain
[8] Univ Girona, Sch Med, Med Sci Dept, Girona 17003, Spain
[9] Ctr Invest Biomed Red, Enfermedades Cardiovasc CIBER CV, Madrid 28029, Spain
来源
JOURNAL OF PERSONALIZED MEDICINE | 2021年 / 11卷 / 06期
关键词
cardiology; pediatrics; congenital heart disease; genetics; OF-FUNCTION MUTATIONS; PATENT DUCTUS-ARTERIOSUS; BICUSPID AORTIC-VALVE; DE-NOVO MUTATIONS; MAKE-UP SYNDROME; MENTAL-RETARDATION; GREAT-ARTERIES; PHENOTYPIC SPECTRUM; MOLECULAR-GENETICS; CAUSE NOONAN;
D O I
10.3390/jpm11060562
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Congenital heart disease is a group of pathologies characterized by structural malformations of the heart or great vessels. These alterations occur during the embryonic period and are the most frequently observed severe congenital malformations, the main cause of neonatal mortality due to malformation, and the second most frequent congenital malformations overall after malformations of the central nervous system. The severity of different types of congenital heart disease varies depending on the combination of associated anatomical defects. The causes of these malformations are usually considered multifactorial, but genetic variants play a key role. Currently, use of high-throughput genetic technologies allows identification of pathogenic aneuploidies, deletions/duplications of large segments, as well as rare single nucleotide variants. The high incidence of congenital heart disease as well as the associated complications makes it necessary to establish a diagnosis as early as possible to adopt the most appropriate measures in a personalized approach. In this review, we provide an exhaustive update of the genetic bases of the most frequent congenital heart diseases as well as other syndromes associated with congenital heart defects, and how genetic data can be translated to clinical practice in a personalized approach.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] Families and the Chronicity of Diagnosis with Congenital Heart Defects
    McGrath, Jacqueline M.
    Kolwaite, Amy
    NEWBORN AND INFANT NURSING REVIEWS, 2006, 6 (03) : 175 - 177
  • [22] Prenatal diagnosis of nonsyndromic congenital heart defects
    Ailes, Elizabeth C.
    Gilboa, Suzanne M.
    Riehle-Colarusso, Tiffany
    Johnson, Candice Y.
    Hobbs, Charlotte A.
    Correa, Adolfo
    Honein, Margaret A.
    PRENATAL DIAGNOSIS, 2014, 34 (03) : 214 - 222
  • [23] Influence of prenatal diagnosis on congenital heart defects
    De Vore, GR
    ULTRASOUND SCREENING FOR FETAL ANOMALIES: IS IT WORTH IT?: SCREENING REVISITED AFTER THE EUROFETUS DATA, 1998, 847 : 46 - 52
  • [24] Prenatal diagnosis of congenital heart defects: echocardiography
    Sun, Heather Y.
    TRANSLATIONAL PEDIATRICS, 2021, 10 (08) : 2210 - 2224
  • [25] Accuracy of prenatal diagnosis of congenital heart defects
    Berghella, V
    Pagotto, L
    Kaufman, M
    Huhta, JC
    Wapner, RJ
    FETAL DIAGNOSIS AND THERAPY, 2001, 16 (06) : 407 - 412
  • [26] Epigenomic signature of major congenital heart defects in newborns with Down syndrome
    Mouat, Julia S.
    Li, Shaobo
    Myint, Swe Swe
    Laufer, Benjamin, I
    Lupo, Philip J.
    Schraw, Jeremy M.
    Woodhouse, John P.
    de Smith, Adam J.
    LaSalle, Janine M.
    HUMAN GENOMICS, 2023, 17 (01)
  • [27] PROSTAGLANDIN-E2 IN NEWBORNS WITH CONGENITAL HEART-DEFECTS
    SCHLEMMER, M
    KHOSS, A
    SALZER, HR
    WIMMER, M
    HERZ KREISLAUF, 1982, 14 (03): : 158 - 158
  • [28] Cardiac hypertrophy suppresses glucose oxidation in newborns with congenital heart defects
    Rawat, Sonia
    Fukushima, Arata
    Zhang, Liyan
    Huqi, Alda
    Altamimi, Tariq
    Wagg, Cory
    Hornberger, Lisa
    Kantor, Paul
    Rebeyka, Ivan
    Lopaschuk, Gary
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 112 : 138 - 138
  • [29] Pulse oximetry as a screening tool for critical congenital heart defects in newborns
    Shahzad, Muhammad
    Waqar, Talal
    Waheed, Khawaja Ahmad Irfan
    Gul, Rafia
    Fatima, Syeda Tahseen
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2017, 67 (08) : 1220 - 1223
  • [30] Epigenomic signature of major congenital heart defects in newborns with Down syndrome
    Julia S. Mouat
    Shaobo Li
    Swe Swe Myint
    Benjamin I. Laufer
    Philip J. Lupo
    Jeremy M. Schraw
    John P. Woodhouse
    Adam J. de Smith
    Janine M. LaSalle
    Human Genomics, 17